S100A4 and prostate carcinoma: These results suggest that the S100A4-embigin axis mediates prostate cancer progression through AMPK suppression, which activates mTORC1 leading to suppression of p21WAF1 expression, which results in the induction of proliferation and inhibition of autophagy.